Decreased expression of protein O-linked mannose β-1,2-N- acetylglucosaminyltransferase 1 contributes to Alzheimer's disease-like pathologies

被引:3
作者
Feng, Yuxue [1 ]
Jiang, Hanxiao [1 ]
Li, Gongbo [1 ]
He, Guiqiong [2 ]
Li, Xiaofeng [1 ]
机构
[1] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 2, Chongqing, Peoples R China
[2] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China
关键词
Alzheimer's disease; mannosylation; POMGnT1; posttranslational modifications; AMYLOID PRECURSOR PROTEIN; POSTTRANSLATIONAL MODIFICATIONS; MOUSE MODELS; TAU; GLYCOSYLATION; BETA; MANNOSYLATION; MUTATIONS; SECRETION; MEMBRANE;
D O I
10.1152/jn.00362.2021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is pathologically characterized by senile plaques and neurofibrillary tangles composed of beta-amyloid peptide (A beta) and tau hyperphosphorylation, respectively. Mannosylation, a particular type of posttranslational modification, may be involved in the pathogenesis of AD. However, its underlying mechanism remains unclear. Protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) catalyzes the formation of the N-acetylglucosamine beta-1,2-Man linkage of O-mannosylglycan, which can increase the protein posttranslational mannosylation level. The defective POMGnT1 gene leads to the hypomannosylation of proteins, which may cause cognitive decline in aged people. This study aimed to investigate whether POMGnT1 participated in the pathogenesis of AD and explore its underlying role using AD mouse and cell models. In this study, the expression of POMGnT1 was measured in AD models [beta-amyloid precursor protein (APP)/presenilin-1 (PS1) transgenic mice, an AD mouse model; N2a cells stably transfected with Swedish mutant APP (N2a/APP), an AD cell model]. The results revealed that the expression of POMGnT1 decreased in AD mouse and cell models. In addition, POMGnTI-overexpressing N2a/APP cells were built by retroviral transfection. POMGnT1 overexpression may lower A beta levels by reducing APP production and downregulating beta- and gamma-secretase activities. It also promoted clearance of A beta by upregulating insulin-degrading enzymes and ameliorated tau hyperphosphorylation. Hence, it was concluded that POMGnT1 was involved in the pathogenic process of AD. The decreased expression of POMGnT1 contributes to AD-like pathologies. NEW & NOTEWORTHY This study explored the role of mannosylation in the pathogenesis of AD through a mannosyltransferase-POMGnT1. Results demonstrated that target gene overexpression could ameliorate pathologies of A beta and tau hyperphosphorylation. This study is the first to examine the relationship between mannosylation and AD.
引用
收藏
页码:1067 / 1074
页数:8
相关论文
共 42 条
[1]   Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain [J].
Abolhassani, Nona ;
Leon, Julio ;
Sheng, Zijing ;
Oka, Sugako ;
Hamasaki, Hideomi ;
Iwaki, Toru ;
Nakabeppu, Yusaku .
MECHANISMS OF AGEING AND DEVELOPMENT, 2017, 161 :95-104
[2]   Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease [J].
Alkadhi, Karim A. ;
Dao, An T. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2018, 86 :25-29
[3]   Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].
Ballatore, Carlo ;
Lee, Virginia M. -Y. ;
Trojanowski, John Q. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672
[4]   Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis [J].
Bloom, George S. .
JAMA NEUROLOGY, 2014, 71 (04) :505-508
[5]   Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy [J].
Booler, Helen S. ;
Williams, Josie L. ;
Hopkinson, Mark ;
Brown, Susan C. .
BRAIN PATHOLOGY, 2016, 26 (04) :465-478
[6]  
Chen J, INT J MOL MED, V44, P313
[7]   O-Mannosylation and human disease [J].
Dobson, Christina M. ;
Hempel, Samuel J. ;
Stalnaker, Stephanie H. ;
Stuart, Ryan ;
Wells, Lance .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (16) :2849-2857
[8]   Neurons and Glia Modify Receptor Protein-tyrosine Phosphatase ζ (RPTPζ)/Phosphacan with Cell-specific O-Mannosyl Glycans in the Developing Brain [J].
Dwyer, Chrissa A. ;
Katoh, Toshihiko ;
Tiemeyer, Michael ;
Matthews, Russell T. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (16) :10256-10273
[9]   A validated antibody panel for the characterization of tau post-translational modifications [J].
Ercan, Ebru ;
Eid, Sameh ;
Weber, Christian ;
Kowalski, Alexandra ;
Bichmann, Maria ;
Behrendt, Annika ;
Matthes, Frank ;
Krauss, Sybille ;
Reinhardt, Peter ;
Fulle, Simone ;
Ehrnhoefer, Dagmar E. .
MOLECULAR NEURODEGENERATION, 2017, 12
[10]  
[冯钰雪 Feng Yuxue], 2019, [中华神经科杂志, Chinese Journal of Neurology], V52, P543